查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598802

子宫肌瘤治疗设备市场：依技术及治疗方法划分－2025年至2030年全球预测

Uterine Fibroid Treatment Device Market by Technology (Ablation Techniques, Embolization Techniques, Laparoscopic Techniques), Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年子宫肌瘤治疗器械市值为5.6039亿美元，预计到2024年将达到6.1832亿美元，复合年增长率为10.43%，预计到2030年将达到11.2236亿美元。

子宫肌瘤治疗设备市场包括为诊断和治疗子宫肌瘤（子宫内的非癌性生长）而开发的专用医疗设备。这些设备在取代子宫切除术等传统手术方法的微创手术中发挥着至关重要的作用。对此类设备的需求是由于子宫肌瘤的盛行率不断增加，尤其是育龄妇女，以及人们越来越偏好减少恢復时间和手术风险的微创手术。主要应用包括诊断和治疗影像技术，例如超音波、射频消融术和腹腔镜设备，这些技术供应给医院、门诊手术中心和专科诊所。

主要市场统计
基准年[2023] 56039万美元
预测年份 [2024] 61832万美元
预测年份 [2030] 112,236 万美元
复合年增长率（%） 10.43%

市场成长受到多种因素的影响，例如医疗技术的进步导致更有效和侵入性更小的治疗选择、医疗保健支出的增加以及对疾病及其治疗选择的认识的提高。人口老化和非裔美国女性发病率上升等人口趋势也进一步推动需求。最近的市场趋势包括在诊断设备中使用人工智慧来提高准确性并开拓易于在新兴市场使用的经济高效的解决方案。为了利用这些优势，公司必须投资新设备的研发，并与医疗保健提供者合作以改善治疗途径。

然而，市场面临着设备成本高、报销挑战以及可能阻碍更广泛采用的监管障碍等限制。一个关键的挑战是患者缺乏认识并且不愿意选择这些新治疗方法而不是传统方法。创新领域包括开发易于使用的门诊设备以及整合远距远端医疗解决方案以扩大患者覆盖范围。市场竞争激烈且充满活力，新参与企业不断推出颠覆性技术。相关人员应专注于持续创新、策略伙伴关係和教育宣传活动，以克服这些障碍并在这个不断变化的环境中保持成长。

市场动态：快速发展的子宫肌瘤治疗设备市场的关键市场洞察

子宫肌瘤治疗设备市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球子宫肌瘤数量增加
    • 对微创设备的偏好日益增长
    • 增加技术先进产品的使用
  • 市场限制因素
    • 新兴经济体缺乏必要的基础设施
  • 市场机会
    • 政府和组织为提高子宫肌瘤诊断相关意识所做的积极努力
    • 引进及开发技术先进的产品
  • 市场挑战
    • 居民子宫肌瘤诊断意识下降

波特的五力：驾驭子宫肌瘤治疗设备市场的策略工具

波特五力是了解子宫肌瘤治疗器械市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解子宫肌瘤治疗设备市场的外部影响

外部宏观环境因素在塑造子宫肌瘤治疗设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解子宫肌瘤治疗器械市场的竞争状况

子宫肌瘤治疗设备市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵子宫肌瘤治疗设备市场供应商的绩效评估

FPNV 定位矩阵是评估子宫肌瘤治疗设备市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划子宫肌瘤治疗设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对子宫肌瘤治疗设备市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 子宫肌瘤的发生率在全球范围内不断增加
      • 人们对微创设备的兴趣日益浓厚
      • 增加技术先进产品的使用
    • 抑制因素
      • 新兴经济体缺乏必要的基础设施
    • 机会
      • 政府和组织为提高对子宫肌瘤诊断的认识而采取的有利倡议
      • 引进及开发技术先进的产品
    • 任务
      • 大众对设备的认知度下降
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章子宫肌瘤治疗设备市场：依技术分类

  • 消融技术
    • 冷冻疗法
    • 水热消融
    • 微波消融
    • 超音波消融
      • 高强度聚焦超音波
      • MRI导引聚焦超音波
  • 栓塞术
  • 腹腔镜技术
    • 腹腔镜子宫肌瘤切除术
    • 肌溶解症
  • 手术技术
    • 子宫切除术
    • 子宫肌瘤切除术

第七章子宫肌瘤治疗设备市场：依治疗方法分类

  • 侵入性治疗
  • 微创治疗
  • 非侵入性治疗

第八章北美和南美子宫肌瘤治疗器械市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太子宫肌瘤治疗器械市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲子宫肌瘤治疗器械市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Advanced Surgical Concepts
  • Boston Scientific Corporation
  • Conmed Corporation
  • Coopersurgical Inc.
  • Gynesonics, Inc.
  • Hologic, Inc.
  • Insightec Ltd.
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Minerva Surgical, Inc.
  • Olympus Corporation
  • Pentax Medical
  • Smith & Nephew PLC
  • Stryker Corporation
Product Code: MRR-0360AB17E12E

The Uterine Fibroid Treatment Device Market was valued at USD 560.39 million in 2023, expected to reach USD 618.32 million in 2024, and is projected to grow at a CAGR of 10.43%, to USD 1,122.36 million by 2030.

The uterine fibroid treatment devices market encompasses specialized medical equipment developed for diagnosing and treating uterine fibroids-non-cancerous growths in the uterus. These devices play a pivotal role in minimally invasive procedures that offer alternatives to traditional surgical methods like hysterectomy. The necessity for such devices stems from the increasing prevalence of uterine fibroids, particularly among women of childbearing age, coupled with a rising preference for minimally invasive procedures that reduce recovery time and surgical risks. Primary applications include imaging and treatment technologies such as ultrasound, radiofrequency ablation, and laparoscopic devices, catering to hospitals, ambulatory surgical centers, and specialty clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 560.39 million
Estimated Year [2024] USD 618.32 million
Forecast Year [2030] USD 1,122.36 million
CAGR (%) 10.43%

Market growth is influenced by factors such as advancements in medical technology leading to more effective and less invasive treatment options, increasing healthcare expenditure, and a growing awareness of the condition and its treatment alternatives. Demographic trends, including an aging population and higher incidence rates among African American women, further drive demand. Recent opportunities within the market involve leveraging AI in diagnostic devices to enhance accuracy and developing cost-effective solutions to widen accessibility in emerging markets. To capitalize on these, companies should invest in R&D for novel devices and collaborate with healthcare providers to improve treatment pathways.

However, the market faces limitations such as high device costs, reimbursement challenges, and regulatory hurdles, which may hinder broader adoption. A significant challenge is the lack of awareness and hesitancy among patients to opt for these newer treatment methods over traditional approaches. Innovation areas include the development of user-friendly devices that can be utilized in outpatient settings and the integration of telemedicine solutions to expand patient reach. The market is competitive and dynamic, with new entrants constantly introducing disruptive technologies. Stakeholders should focus on continuous innovation, strategic partnerships, and educational campaigns to overcome these barriers and sustain growth in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing occurrence of uterine fibroid worldwide
    • Growing penchant for minimally invasive devices
    • Rising utilization of technologically advanced products
  • Market Restraints
    • Shortage of required infrastructure in developing economies
  • Market Opportunities
    • Favorable initiatives by governments and organizations to increase awareness pertinent to uterine fibroid diagnosis
    • Introduction and development of technologically advanced products
  • Market Challenges
    • Reduced awareness of the device among population

Porter's Five Forces: A Strategic Tool for Navigating the Uterine Fibroid Treatment Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Uterine Fibroid Treatment Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Uterine Fibroid Treatment Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Uterine Fibroid Treatment Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Uterine Fibroid Treatment Device Market

A detailed market share analysis in the Uterine Fibroid Treatment Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Uterine Fibroid Treatment Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Uterine Fibroid Treatment Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Uterine Fibroid Treatment Device Market

A strategic analysis of the Uterine Fibroid Treatment Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Uterine Fibroid Treatment Device Market, highlighting leading vendors and their innovative profiles. These include Advanced Surgical Concepts, Boston Scientific Corporation, Conmed Corporation, Coopersurgical Inc., Gynesonics, Inc., Hologic, Inc., Insightec Ltd., Karl Storz SE & Co. KG, Medtronic PLC, Merit Medical Systems, Inc., Minerva Surgical, Inc., Olympus Corporation, Pentax Medical, Smith & Nephew PLC, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Uterine Fibroid Treatment Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Ablation Techniques, Embolization Techniques, Laparoscopic Techniques, and Surgical Techniques. The Ablation Techniques is further studied across Cryoablation, Hydrothermal Ablation, Microwave Ablation, and Ultrasound Ablation. The Ultrasound Ablation is further studied across High Intensity Focused Ultrasound and MRI-Guided Focused Ultrasound. The Laparoscopic Techniques is further studied across Laparoscopic Myomectomy and Myolysis. The Surgical Techniques is further studied across Hysterectomy and Myomectomy.
  • Based on Mode of Treatment, market is studied across Invasive Treatment, Minimally Invasive Treatment, and Non-Invasive Treatment.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing occurrence of uterine fibroid worldwide
      • 5.1.1.2. Growing penchant for minimally invasive devices
      • 5.1.1.3. Rising utilization of technologically advanced products
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of required infrastructure in developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable initiatives by governments and organizations to increase awareness pertinent to uterine fibroid diagnosis
      • 5.1.3.2. Introduction and development of technologically advanced products
    • 5.1.4. Challenges
      • 5.1.4.1. Reduced awareness of the device among population
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Uterine Fibroid Treatment Device Market, by Technology

  • 6.1. Introduction
  • 6.2. Ablation Techniques
    • 6.2.1. Cryoablation
    • 6.2.2. Hydrothermal Ablation
    • 6.2.3. Microwave Ablation
    • 6.2.4. Ultrasound Ablation
      • 6.2.4.1. High Intensity Focused Ultrasound
      • 6.2.4.2. MRI-Guided Focused Ultrasound
  • 6.3. Embolization Techniques
  • 6.4. Laparoscopic Techniques
    • 6.4.1. Laparoscopic Myomectomy
    • 6.4.2. Myolysis
  • 6.5. Surgical Techniques
    • 6.5.1. Hysterectomy
    • 6.5.2. Myomectomy

7. Uterine Fibroid Treatment Device Market, by Mode of Treatment

  • 7.1. Introduction
  • 7.2. Invasive Treatment
  • 7.3. Minimally Invasive Treatment
  • 7.4. Non-Invasive Treatment

8. Americas Uterine Fibroid Treatment Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Uterine Fibroid Treatment Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Uterine Fibroid Treatment Device Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Surgical Concepts
  • 2. Boston Scientific Corporation
  • 3. Conmed Corporation
  • 4. Coopersurgical Inc.
  • 5. Gynesonics, Inc.
  • 6. Hologic, Inc.
  • 7. Insightec Ltd.
  • 8. Karl Storz SE & Co. KG
  • 9. Medtronic PLC
  • 10. Merit Medical Systems, Inc.
  • 11. Minerva Surgical, Inc.
  • 12. Olympus Corporation
  • 13. Pentax Medical
  • 14. Smith & Nephew PLC
  • 15. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. UTERINE FIBROID TREATMENT DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UTERINE FIBROID TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. UTERINE FIBROID TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. UTERINE FIBROID TREATMENT DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. UTERINE FIBROID TREATMENT DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYDROTHERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MRI-GUIDED FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY EMBOLIZATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MINIMALLY INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY NON-INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 280. UTERINE FIBROID TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. UTERINE FIBROID TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023